Table of Contents 1 Study Coverage 1.1 Chemotherapy-induced Nausea and Vomiting Drugs Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by Product 1.4.2 5-HT3 Inhibitors 1.4.3 NK1 Inhibitors 1.4.4 Other 1.5 Market by End User 1.5.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by End User 1.5.2 Highly Emetogenic Chemotherapy 1.5.3 Moderately Emetogenic Chemotherapy 1.5.4 Low Emetogenic Chemotherapy 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size 2.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue 2014-2025 2.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales 2014-2025 2.2 Chemotherapy-induced Nausea and Vomiting Drugs Growth Rate by Regions 2.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Regions 2.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers 3.1.1 Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers 3.1.2 Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers 3.1.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers 3.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2014-2019) 3.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2014-2019) 3.3 Chemotherapy-induced Nausea and Vomiting Drugs Price by Manufacturers 3.4 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturing Base Distribution, Product Types 3.4.1 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Chemotherapy-induced Nausea and Vomiting Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Product 4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Product 4.3 Chemotherapy-induced Nausea and Vomiting Drugs Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Breakdown Data by End User 6 North America 6.1 North America Chemotherapy-induced Nausea and Vomiting Drugs by Countries 6.1.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries 6.1.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Chemotherapy-induced Nausea and Vomiting Drugs by Product 6.3 North America Chemotherapy-induced Nausea and Vomiting Drugs by End User 7 Europe 7.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs by Countries 7.1.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries 7.1.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs by Product 7.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs by End User 8 Asia Pacific 8.1 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs by Countries 8.1.1 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries 8.1.2 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs by Product 8.3 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs by End User 9 Central & South America 9.1 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs by Countries 9.1.1 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries 9.1.2 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs by Product 9.3 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs by End User 10 Middle East and Africa 10.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs by Countries 10.1.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries 10.1.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs by Product 10.3 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs by End User 11 Company Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Company Business Overview 11.1.3 Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Merck Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.1.5 Merck Recent Development 11.2 Eisai 11.2.1 Eisai Company Details 11.2.2 Company Business Overview 11.2.3 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.2.5 Eisai Recent Development 11.3 Mundipharma 11.3.1 Mundipharma Company Details 11.3.2 Company Business Overview 11.3.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.3.5 Mundipharma Recent Development 11.4 Qilu Pharma 11.4.1 Qilu Pharma Company Details 11.4.2 Company Business Overview 11.4.3 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.4.5 Qilu Pharma Recent Development 11.5 Teva 11.5.1 Teva Company Details 11.5.2 Company Business Overview 11.5.3 Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Teva Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.5.5 Teva Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Company Business Overview 11.6.3 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.6.5 Novartis Recent Development 11.7 Heron Therapeutics 11.7.1 Heron Therapeutics Company Details 11.7.2 Company Business Overview 11.7.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.7.5 Heron Therapeutics Recent Development 11.8 Roche 11.8.1 Roche Company Details 11.8.2 Company Business Overview 11.8.3 Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Roche Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.8.5 Roche Recent Development 11.9 Mylan 11.9.1 Mylan Company Details 11.9.2 Company Business Overview 11.9.3 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.9.5 Mylan Recent Development 11.10 Tesaro 11.10.1 Tesaro Company Details 11.10.2 Company Business Overview 11.10.3 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Products Offered 11.10.5 Tesaro Recent Development 12 Future Forecast 12.1 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by Regions 12.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Regions 2019-2025 12.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast by Regions 2019-2025 12.2 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by Product 12.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Product 2019-2025 12.2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast by Product 2019-2025 12.3 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by End User 12.4 North America Chemotherapy-induced Nausea and Vomiting Drugs Forecast 12.5 Europe Chemotherapy-induced Nausea and Vomiting Drugs Forecast 12.6 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Forecast 12.7 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Forecast 12.8 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Chemotherapy-induced Nausea and Vomiting Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Chemotherapy-induced Nausea and Vomiting Drugs Product Picture Table Chemotherapy-induced Nausea and Vomiting Drugs Market Segments Table Key Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Covered Table Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Product 2014-2025 Figure 5-HT3 Inhibitors Product Picture Table Major Manufacturers of 5-HT3 Inhibitors Figure NK1 Inhibitors Product Picture Table Major Manufacturers of NK1 Inhibitors Figure Other Product Picture Table Major Manufacturers of Other Table Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Growth Rate by End User 2019-2025 (K Units) Figure Highly Emetogenic Chemotherapy Figure Moderately Emetogenic Chemotherapy Figure Low Emetogenic Chemotherapy Figure Other Figure Chemotherapy-induced Nausea and Vomiting Drugs Report Years Considered Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size 2014-2025 (Million US$) Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales 2014-2025 (K Units) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Regions 2014-2019 (K Units) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Regions 2014-2019 Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Regions 2014-2019 Figure 2018 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Regions Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Regions 2014-2019 (Million US$) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Regions 2014-2019 Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Regions 2014-2019 Figure 2018 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Regions Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (2014-2019) (K Units) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Manufacturers (2014-2019) Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2014-2019) (Million USD) Table Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2014-2019) Figure Chemotherapy-induced Nausea and Vomiting Drugs Value Share by Manufacturers in 2018 Table Key Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Price (2014-2019) (USD/Unit) Table Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Product Type Table Date of International Manufacturers Enter into Chemotherapy-induced Nausea and Vomiting Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Product (2014-2019) (K Units) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Product (2014-2019) Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Product (2014-2019) Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Product in 2018 Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Product (2014-2019) (Million US$) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Product (2014-2019) Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Product (2014-2019) Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Product in 2018 Table Chemotherapy-induced Nausea and Vomiting Drugs Price by Product 2014-2019 (USD/Unit) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by End User (2014-2019) (K Units) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by End User (2014-2019) Figure Global Sales Chemotherapy-induced Nausea and Vomiting Drugs Market Share by End User (2014-2019) Figure Global Sales Chemotherapy-induced Nausea and Vomiting Drugs Market Share by End User in 2018 Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate 2014-2019 (K Units) Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate 2014-2019 (Million US$) Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2014-2019) (K Units) Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2014-2019) Figure 2018 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2014-2019) (Million US$) Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries Figure United States Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure United States Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (K Units) Figure Canada Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Canada Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Mexico Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Product (2014-2019) (K Units) Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Product (2014-2019) Figure 2018 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Product Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by End User (2014-2019) (K Units) Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by End User (2014-2019) Figure 2018 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Share by End User Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate 2014-2019 (K Units) Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2014-2019) (K Units) Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2014-2019) (Million US$) Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries Figure Germany Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Germany Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure France Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure France Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure UK Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure UK Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Italy Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Russia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Product (2014-2019) (K Units) Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Product (2014-2019) Figure 2018 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Product Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by End User (2014-2019) (K Units) Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by End User (2014-2019) Figure 2018 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Share by End User Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2014-2019) (K Units) Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries Figure China Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure China Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Japan Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Korea Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure India Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure India Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Australia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Philippines Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Thailand Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Singapore Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Product (2014-2019) (K Units) Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Product Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by End User (2014-2019) (K Units) Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Share by End User Figure Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2014-2019) (K Units) Table Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries Table Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2014-2019) (Million US$) Table Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries Figure Brazil Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Brazil Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Argentina Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Product (2014-2019) (K Units) Table Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Product Table Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by End User (2014-2019) (K Units) Table Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Market Share by End User Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries Figure GCC Countries Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Turkey Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure Egypt Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2014-2019) (K Units) Figure South Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Product (2014-2019) (K Units) Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Product Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by End User (2014-2019) (K Units) Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Share by End User Table Merck Company Details Table Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Recent Development Table Eisai Company Details Table Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Eisai Recent Development Table Mundipharma Company Details Table Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Mundipharma Recent Development Table Qilu Pharma Company Details Table Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Qilu Pharma Recent Development Table Teva Company Details Table Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Recent Development Table Novartis Company Details Table Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Recent Development Table Heron Therapeutics Company Details Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Heron Therapeutics Recent Development Table Roche Company Details Table Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Recent Development Table Mylan Company Details Table Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Mylan Recent Development Table Tesaro Company Details Table Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Tesaro Recent Development Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Regions 2019-2025 (K Units) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Regions 2019-2025 Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Regions 2019-2025 Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Product 2019-2025 (K Units) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Product 2019-2025 Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast by Product 2019-2025 (Million US$) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Product 2019-2025 Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by End User 2019-2025 (K Units) Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by End User 2019-2025 Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Chemotherapy-induced Nausea and Vomiting Drugs Value Chain Table Chemotherapy-induced Nausea and Vomiting Drugs Customers List Table Chemotherapy-induced Nausea and Vomiting Drugs Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Merck Eisai Mundipharma Qilu Pharma Teva Novartis Heron Therapeutics Roche Mylan Tesaro